Health · 4 views
Drug discovery by scientists joins world's largest trial of Parkinson's treatments
A liver drug could be used to slow down the progression of Parkinson's disease as it joins the world's largest trial of treatments for the condition.
Summary
A liver drug could be used to slow down the progression of Parkinson's disease as it joins the world's largest trial of treatments for the condition. This comes after researchers at the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust discovered that ursodeoxycholic acid (UDCA) has considerable promise to improve the function of mitochondria, known as the cell's power plants, in Parkinson's disease and, by doing so, slow the progression of this currently relentlessly progressive disease.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Drug restores kidney cell function in experimental models of rare Lowe syndromeContinue reading
- Autism, masking, and building a more inclusive world | LettersContinue reading
- STAT+: New tumor cases show common gene therapy tool can come with riskContinue reading
- FDA Approves Dual-Targeted Therapy for Head and Neck CancerContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow